XML 96 R83.htm IDEA: XBRL DOCUMENT v3.25.1
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL INFORMATION - Effect On Statement of Cash Flows (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:                
Net Loss Attributable To Common Stockholders $ (6,088,711) $ (7,322,430) $ (10,383,820) $ (13,923,650) $ (13,151,343) $ (23,111,909)   $ (29,246,760)
Adjustments to reconcile net loss to net cash used in operating activities:                
Stock-Based Compensation 959,465 1,077,033 1,949,013 1,739,711 2,868,960 3,087,100   4,155,342
Inventories   1,747,144   1,449,881   471,822 $ 500,466 183,273
Accounts payable and accrued expenses (1,281,724) 629,833 (2,032,014) 291,068 (3,165,684) 1,047,700 (1,807,575) 1,607,366
Supplemental disclosure of non-cash financing activities:                
Settlement of accrued bonuses with restricted stock units             $ 197,892 403,939
As previously reported                
Cash flows from operating activities:                
Net Loss Attributable To Common Stockholders (6,357,861) (7,325,883) (10,501,007) (13,478,967) (12,835,098) (22,672,487)   (28,507,394)
Adjustments to reconcile net loss to net cash used in operating activities:                
Stock-Based Compensation 924,304 1,080,486 1,761,888 1,295,028 2,248,403 2,647,678   3,700,704
Inventories   1,747,144   1,449,881   471,822   (121,039)
Accounts payable and accrued expenses (1,281,724) 629,833 (2,032,014) 291,068 (3,165,684) 1,047,700   1,623,580
Effect of restatement                
Cash flows from operating activities:                
Net Loss Attributable To Common Stockholders 269,150 3,453 117,187 (444,683) (316,245) (439,422)   (739,366)
Adjustments to reconcile net loss to net cash used in operating activities:                
Stock-Based Compensation 35,161 (3,453) 187,125 444,683 620,557 439,422   454,638
Inventories               304,312
Accounts payable and accrued expenses 190,094 (250,206) 181,657 366,410 (364,581) 432,320   221,923
Non-cash reclassification to additional paid-in-capital                
Adjustments to reconcile net loss to net cash used in operating activities:                
Accounts payable and accrued expenses $ (190,094) $ 250,206 $ (181,657) $ (366,410) $ 364,581 $ (432,320)   $ (238,137)